# FDA Warning Letter: Grimann S.A. de C.V.
> 2022-05-31 · Center for Drug Evaluation and Research | CDER · `aecc48c1da12cb8b`
## Letter
- **Company:** Grimann S.A. de C.V.
- **Posted Date:** 2022-05-31
- **Letter Issue Date:** 2022-05-23
- **Issuing Office:** Center for Drug Evaluation and Research | CDER
## Subject
Failure to Comply with Drug Registration and Listing Requirements
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*